Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5037
+0.0137 (2.80%)
At close: Sep 17, 2026, 4:00 PM EDT
0.5067
+0.0030 (0.60%)
After-hours: Sep 17, 2026, 4:10 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.83 million as of September 17, 2026. Its market cap has increased by 203.83% in one year.
Market Cap
16.83M
Enterprise Value
-28.83M
1-Year Change
203.83%
Ranking
Category
Stock Price
$0.50
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.83M, a decrease of -74.22%. That is a compound annual growth rate of -23.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 16.83M | -43.50% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 18.95M |
| Allarity Therapeutics | 18.62M |
| Lipocine | 18.30M |
| BioCardia | 18.02M |
| Chemomab Therapeutics | 17.75M |
| Niki BioSolutions | 17.16M |
| Cerenome | 16.47M |
| Passage Bio | 15.82M |